Abivax SA American Depositary Shares (ABVX) is a publicly traded Healthcare sector company. As of May 21, 2026, ABVX trades at $120.18 with a market cap of $9.00B and a P/E ratio of 0.00. ABVX moved +5.32% today. Year to date, ABVX is -2.70%; over the trailing twelve months it is +1967.24%. Its 52-week range spans $4.77 to $148.83. Analyst consensus is strong buy with an average price target of $152.25. Rallies surfaces ABVX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own ABVX include Orbimed Advisors, Centerbook Partners, and Farallon Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Abivax SA American Depositary Shares.
| Metric | Value |
|---|---|
| Price | $120.18 |
| Market Cap | $9.00B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $148.83 |
| 52-Week Low | $4.77 |
| Volume | 3.45K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
8 analysts cover ABVX: 0 strong buy, 7 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $152.25.